Résumé des résultats (Abstract)
(Anglais)
|
Trojan Therapeutics is developing gene-engineered macrophages, which attack and destroy tumors from the inside. The lead indication is triple negative breast cancer, a poor prognosis disease with no efficient therapies available and we aim to develop an efficient therapy for these patients.
|
